About
Pharmacogenomics test for hypertension
Areas of Focus
Categories
DiagnosticsMidwest
Team (12)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
1,958
By Phase
PHASE2: 1PHASE4: 1
By Status
COMPLETED: 3UNKNOWN: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT02988245Lead Sponsor
Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension
PHASE2Unknown
1,000 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2023
NCT04060641Lead Sponsor
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
N/AUnknown
30 participants
Started: Dec 5, 2019 · Completed: Sep 30, 2022
NCT03292900Lead Sponsor
Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment
N/ACompleted
758 participants
Started: Mar 1, 2018 · Completed: Jan 15, 2019
NCT02524873Lead Sponsor
Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension
N/ACompleted
99 participants
Started: Apr 30, 2015 · Completed: Jun 30, 2015
NCT00858416Lead Sponsor
Combined Vibrations, Passive Motion and Thermotherapy for Knee Osteoarthritis
PHASE4Completed
71 participants
Started: Apr 30, 2006 · Completed: Mar 31, 2007
Locations (1)
Headquarters
Rochester, MN, United States
Map
Loading map...